← Coming soon·

BITTI Bittium Oyj

OMXH · Helsinki — full main listsingle-model previewUpdated 2026-07-04

Single AI model preview (DeepSeek): Bittium Oyj estimate 21.24 € vs market price 33.15 € (-35.9%). Analyst coverage: 4. Experimental research — not investment advice.

Spot
33.15 €
Preview est.
21.24 €
Gap
-35.9%
Analysts
4
Market cap
1.2 B €
52-week range
8.24 €43.70 €
Sector
technology

About the company

Bittium Oyj provides communications and connectivity solutions under the Bittium brand in Finland, the rest of Europe, the Americas, and Asia. It operates through Defense & Security, Medical, and Engineering Services segments. The company offers Faros, an ECG monitor for early detection of cardiac abnormalities; OmegaSnap, a wearable disposable patch electrode for long-term ECG measurements; Cardiac Navigator, a software solution for analyzing clinical Holter ECG recordings; MedicalSuite, a cloud-based software-as-a-service solution for data sharing and management; Respiro, a recording device for nocturnal polygraph examinations; BrainStatus, a wireless and compact EEG amplifier for continuous EEG measurements in intensive care units; and NeurOne, an EEG/ERP device. It also provides Tough Mobile, Tough Mobile 2, and Tough Mobile 2 Tactical smartphones; Secure Suite, a device management and encryption software; Secure Call, a communication application; SafeMove Mobile VPN; SafeMove Analytics, a monitoring and reporting module; Tactical Wireless IP Network, a software-defined radio-based wireless broadband network system; Tough SDR; Tough VoIP; Tough Comnode; Tough VoIP Field Phone;

Source: Yahoo Finance

Model assumptions (DeepSeek)

Revenue CAGR (5y)
10.0 %
EBIT margin target
18.0 %
WACC
10.0 %
Terminal growth
2.0 %
Model confidence
55 %
The estimate runs these assumptions through the same deterministic valuation engine as the live universe. Valuation Methodology

Weekly snapshots

DateSpotPreview est.Gap
2026-07-0433.15 €21.24 €-35.9%
2026-07-0332.60 €24.70 €-24.2%
2026-07-0232.10 €23.78 €-25.9%
Experimental research — not investment advice. Preview estimates come from a single AI model and differ from the live 5-model consensus.